Keane W.F. . .Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study. Clinical Journal of the American Society of Nephrology, 1(2006) : 1-7.
.2024 .Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathway. ” Scientific Reports, 14 : 11167.
Klisic .2018 .Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2.” Clinical and Experimental Medicine. , 18 : 283-290.
Hasan M. .2022 .Assessment of the relationship between serum xanthine oxidase levels and type 2 diabetes: A crosssectional study. ” Scientific Reports, 12 : 20816.
Nakatani S. .2021 .Plasma xanthine oxidoreductase activity associated with glycaemic control in patients with pre-dialysis chronic kidney disease. ” Kidney and Blood Pressure Research, 46 : 475-483.
Washio K. .2020 .Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes. ” Acta Diabetologica, 57 : 31-39.
Shabani F. .2020 .Human & Experimental Toxicology. , 39 : 1031-1045.
Garcia V. .2022 .A structural perspective on calprotectin as a ligand of receptors mediating inflammation and potential drug target. ” Biomolecules, 12 : 519.
Sekimoto R. .2012 .High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. ” Biochemical and Biophysical Research Communications, 419 : 782-789.
Oosterwijk M.M. .2020 .Determinants of increased serum calprotectin in patients with type 2 diabetes mellitus. International Journal of Molecular Sciences, 21 : 8075.
Ortega F.J. .2012 .Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. European Journal of Endocrinology, 167 : 569-578.
Jukic A. .2021 .Calprotectin: From biomarker to biological function. ” Gut, 70 : 1978-1988.
Afify M. .2022 .The relationship between serum calprotectin and peripheral neuropathy in a sample of Egyptian type 2 diabetic patients. ” Ain Shams Medical Journal, 73 : 153-169.
Mostafa ,April 2024 . .Serum calprotectin in patients with type 2 diabetes mellitus and its relation to microvascular complications.” Alexamed ePosters. , 6(2) : 13-14.
Tan C.E. .2001 .Cardiovascular risk factors and LDL sub fraction profile in type 2 diabetes mellitus subjects with good glycaemic control. ” Diabetes Research and Clinical Practice, 51 : 107-114.
Annette M.,Jeffrey B. .2003 .Aging and insulin secretion. American Journal of Physiology-Endocrinology and Metabolism, : .
Majid .2018 .Study of some biochemical parameters for patients with type II diabetes mellitus in Thi-Qar Governorate. ” Journal of Pharmaceutical Sciences and Research, 10(11) : 2938-2941.
Ullah .2023 .Assessment of serum urea and creatinine levels in diabetic patient. BioScientific Review, 5(3) : .
Liu X. . .Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention. ” Renal Failure, 44(2022) : 790-805.
Rasool Ali,Abdul Ali .2023 .Mawj Abdel Razzak Ahmed. “Impact of activity of xanthine oxidase on some biomarkers in patients with kidney stones in Iraqi patients. ” Mustansiriya Medical Journal, 27 : 23.
Korsmo . .Emerging roles of xanthine oxidoreductase in chronic kidney disease. ” Antioxidants, 13(2024) : 712.
Maejima I. .2013 .Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. The EMBO Journal, 32 : 2336-2347.
Lusco M. .2017 .AJKD Atlas of renal pathology: Gouty nephropathy. American Journal of Kidney Diseases, 69 : e5-e6.
Cao L. .2021 .Performance of ultrasound in the clinical evaluation of gout and hyperuricemia. ” Journal of Immunology Research, : 5550626.
Hasan ,December .2022 .Assessment of the relationship between serum xanthine oxidase levels and type 2 diabetes: A cross-sectional study. ” Scientific Reports, 12(1) : .
Oosterwijk M.M. .2020 .Determinants of increased serum calprotectin in patients with type 2 diabetes mellitus. International Journal of Molecular Sciences, 21 : 8075.
Mandrekar J.N. . .Simple statistical measures for diagnostic accuracy assessment. ” Journal of Thoracic Oncology, 5(2010) : 763-764.
Akpotaire P.A. and S.A.,Seriki P.A. and S.A. . .Assessment and correlation of serum urea and creatinine levels in normal, hypertensive and diabetic persons in Auchi, Nigeria. Clinical Research, 7(2023) : 7-16.